Philips and Reinier de Graaf Hospital Expand Existing Strategic Partnership

PhilipsRoyal Philips N.V. (NYSE: PHG, AEX: PHIA) and the 622-bed Reinier de Graaf hospital (Delft, the Netherlands) have announced the signing of an additional 15-year partnership agreement. The agreement, which will give the entire hospital long-term continuous access to Philips' advanced diagnostic and interventional ultrasound technologies, represents a significant extension of an existing multi-year partnership entered into in September 2014. Being the most extensive and holistic agreement for ultrasound ever signed by Philips in the Netherlands, this new agreement emphasizes Philips' global technology leadership in medical ultrasound as well as its role as an accountable business partner.

The new agreement applies to all of the hospital's departments and sites, including a new principal site that will open in August of this year. This latest generation of ultrasound systems being supplied as part of the agreement will offer simplified workflows and a powerful combination of speed and image clarity. The systems will be used, among other applications, for abdominal examinations and for examinations during pregnancy, but will also play an important role in the treatment of rheumatism and the image-guided treatment of patients with cardiovascular disease, performed using the latest live 3D imaging technologies.

This next step in the collaboration between Reinier de Graaf hospital and Philips marks a substantial expansion of the existing partnership between Philips and Reinier de Graaf. The existing partnership already gives the hospital fast and continuous access to the latest diagnostic and interventional imaging systems and clinical informatics solutions as well as innovative planning and consultancy services to help improve the quality and efficiency of healthcare provision. With current and future health care developments in mind, flexibility is one of the core elements of this partnership, enabling the optimal level of patient care and operational efficiency.

Working with a single family of ultrasound systems, all with similar interfaces and usability, hospital personnel will soon be able to work with ultrasound more easily and more efficiently. Ultrasound systems will be easily interchangeable between healthcare professionals and departments - for example, when additional capacity or functionality is needed. Training hospital personnel will also be more efficient.

"Reinier de Graaf carefully considered which ultrasound systems will be required after the move to our new hospital site," said Jaap van den Heuvel, CEO Reinier de Graaf hospital. "We firmly believe that we now have a balanced package that will enable every department to offer the required ultrasound diagnostics. Thanks to this partnership collaboration with Philips, we will now be able to tailor our equipment in a flexible way to suit future developments."

"Philips is changing from a supplier of medical technology to a service provider that supports hospitals across the healthcare continuum, both in terms of the quality of healthcare and in terms of performance and efficiency," said Henk Valk, General Manager of Philips Healthcare Benelux. "We are finding that hospitals are increasingly opting for this strategic partnership model. The new agreement with the Reinier de Graaf hospital shows how, through partnerships like these and the experiences and the relationship of trust that arise from them, we are able to explore additional areas where we can deliver added value for one another."

The new ultrasound systems will be operational with effect from May of this year. Philips is a global leader in medical ultrasound. Thanks to its cost-effectiveness and flexibility, ultrasound is one of the fastest-growing imaging modalities in the market. With its technology leadership, Philips has been able to build a broad and complete portfolio of ultrasound solutions for both diagnostics and interventional therapy.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...